Revvity to Present at Upcoming Investor Conferences
February 21 2024 - 8:00AM
Business Wire
Revvity, Inc. (NYSE: RVTY) today announced it will present at
the following investor conferences in February and March 2024:
Citi's 2024 Unplugged MedTech and Life Sciences Access Day - New
York City, NY Thursday, February 29, 2024 8:00 a.m. ET - Max
Krakowiak, senior vice president and chief financial officer
TD Cowen 44th Annual Health Care Conference – Boston, MA Monday,
March 4, 2024 9:10 a.m. ET - Prahlad Singh, president and chief
executive officer
Raymond James 45th Annual Institutional Investors Conference –
Orlando, FL Tuesday, March 5, 2024 9:15 a.m. ET - Max Krakowiak
Barclays Global Healthcare Conference – Miami, FL Tuesday, March
12, 2024 9:30 a.m. ET - Prahlad Singh
KeyBanc 4th Annual Life Sciences & MedTech Investor Forum -
Virtual Wednesday, March 20, 2024 9:00 a.m. ET– Yves Dubaquie,
senior vice president, diagnostics and Steve Willoughby, senior
vice president, investor relations & ESG
Attendees will receive an update on the Company and its
strategic priorities.
Live audio webcasts will be available on the Events section of
the Company’s website. Replays of the presentations will be posted
on the Revvity Investor Relations website after the events and will
be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is
a call to action. Revvity provides health science solutions,
technologies, expertise and services that deliver complete
workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with
specialized focus areas in translational multi-omics technologies,
biomarker identification, imaging, prediction, screening, detection
and diagnosis, informatics and more.
With 2023 revenue of more than $2.7 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221061578/en/
Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Media Relations: Chet Murray (781) 663-5719
chet.murray@revvity.com
Revvity (NYSE:RVTY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Revvity (NYSE:RVTY)
Historical Stock Chart
From Oct 2023 to Oct 2024